Evaluation of Allocetra by Intra-articular Injection for the Treatment of Temporomandibular Joint Osteoarthritis (TMJ-OA)
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This study is a single center trial to assess the safety and initial efficacy of intra-articular administration of Allocetra to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:
• Diagnosed with temporomandibular OA in the target TMJ.
• Inflammatory findings by Magnetic Resonance Imaging (MRI).
• Acceptable blood workup results (CBC, electrolytes, kidney and liver function).
Locations
Other Locations
Israel
Sheba Medical Center
RECRUITING
Ramat Gan
Contact Information
Primary
Amit Druyan, Dr.
Amit.Druyan@sheba.health.gov.il
972-3-5304413
Backup
Tehila Biton
tehila.biton@sheba.health.gov.il
972-3-5304413
Time Frame
Start Date: 2024-12-15
Estimated Completion Date: 2026-04-08
Participants
Target number of participants: 6
Treatments
Experimental: Intra-articular Injection of Allocetra performed once on Day 1 of the study
Related Therapeutic Areas
Sponsors
Collaborators: Sheba Medical Center
Leads: Dr. Amit Druyan